whole
viru
genom
sequenc
obtain
either
directli
patient
sampl
cultur
virus
number
patient
hospitalis
pneumonia
wuhan
show
aetiolog
agent
betacoronaviru
belong
new
clade
subgenu
sarbecoviru
orthocoronavirina
phylogenet
studi
new
viru
show
share
nucleotid
homolog
well
two
sarslik
coronavirus
isol
chines
horsesho
bat
rhinolophu
sinicu
zhoushan
share
nucleotid
third
sarslik
coronaviru
intermedi
horsesho
bat
r
affini
share
nucleotid
base
establish
practic
new
viru
name
coronaviru
studi
group
intern
committe
taxonomi
diseas
caus
viru
move
anim
human
popul
yet
determin
outbreak
clearli
began
epidemiolog
wuhan
market
number
environment
sampl
around
live
anim
section
market
subsequ
found
posit
base
current
evid
may
actual
emerg
market
earliest
recognis
case
infect
elderli
infirm
man
develop
symptom
decemb
none
famili
member
becam
infect
sourc
viru
remain
furthermor
first
case
contact
seafood
anoth
report
five
first
seven
case
link
seafood
thu
seem
like
viru
amplifi
market
market
might
site
origin
sourc
outbreak
recent
phyloepidemiolog
studi
suggest
viru
circul
unrecognis
novemb
import
seafood
market
elsewher
subsequ
angiotensinconvert
enzym
ii
known
cell
receptor
sarscov
also
sarslik
bat
sequenc
studi
found
receptorbind
domain
viru
suffici
similar
sarscov
indic
could
effici
use
human
receptor
entri
human
infect
experi
undertaken
hela
cell
express
express
human
bat
civet
pig
mice
result
confirm
viru
abl
use
entri
receptor
cell
molecular
model
indic
bind
affin
may
even
higher
sarscov
may
therefor
effici
infect
human
evid
sequenc
analys
clearli
indic
reservoir
host
viru
bat
probabl
chines
intermedi
horsesho
bat
probabl
like
sarscov
intermedi
host
sourc
outbreak
ensur
futur
crossspeci
transmiss
event
new
viru
occur
futur
import
identifi
reservoir
intermedi
wildlif
host
closest
known
wildlif
sequenc
remain
sequenc
viru
isol
intermedi
horsesho
bat
signific
differ
receptorbind
domain
two
virus
malayan
pangolin
mani
javanica
suggest
potenti
intermedi
host
sarslik
virus
identifi
pangolin
seiz
antismuggl
oper
southern
china
share
homolog
possibl
intermedi
wildlif
host
propos
time
next
gener
sequenc
ng
carri
lung
lavag
sampl
patient
decemb
would
demonstr
presenc
sarsrel
inform
wide
avail
sequenc
report
januari
interestingli
first
time
ng
alert
world
new
zoonot
viru
viru
isol
suggest
new
procedur
report
outbreak
base
ng
rather
pathogen
isol
identif
need
result
inform
flow
great
improv
experi
sarscov
import
continu
improv
lack
earliest
possibl
inform
sequenc
slow
develop
diagnost
prepared
capac
lack
earli
inform
may
extend
case
notif
case
report
januari
model
suggest
may
case
unreport
inde
number
case
subsequ
confirm
humantohuman
transmiss
wide
shown
health
care
commun
famili
set
domin
mode
transmiss
respiratori
tract
via
droplet
indirectli
via
fomit
lesser
extent
via
aerosol
addit
sarscov
merscov
infect
human
gastrointestin
suggest
faecalor
spread
may
occur
reproduct
number
ro
gener
thought
although
higher
reproduct
number
suggest
report
mean
incub
time
appear
rang
day
upper
limit
around
day
increas
knowledg
viru
load
one
studi
symptomat
patient
higher
viral
load
detect
soon
symptom
onset
viral
load
higher
nose
throat
singl
asymptomat
patient
viral
load
similar
symptomat
second
detail
studi
viru
load
investig
consecut
day
two
patient
time
hospitalis
serial
sampl
throat
swab
sputum
urin
stool
viral
load
peak
around
day
symptom
onset
copiesml
author
also
studi
viral
load
throat
swab
sputum
stool
sampl
patient
found
viral
load
high
copiesml
throat
sampl
median
sputum
addit
viru
detect
rtpcr
stool
confirm
case
titr
lower
respiratori
sever
studi
indic
transmiss
may
occur
incub
asymptomat
mild
number
import
question
still
answer
transmiss
dynam
includ
inform
infect
incub
period
length
time
viru
load
incub
symptomat
period
viru
shed
incid
infecti
asymptomat
case
risk
vertic
transmiss
mother
mode
transmiss
faec
saliva
urin
evid
viru
isol
initi
famili
cluster
found
evid
viru
stool
sinc
detect
faec
pcr
cultur
one
patient
evid
viru
urin
number
mild
asymptomat
case
determin
rel
case
record
probabl
current
figur
see
tip
iceberg
mani
case
remain
pose
greatest
threat
increas
viru
inform
also
need
stabil
viru
environ
better
determin
transmiss
risk
especi
surviv
viru
aerosol
hard
surfac
differ
condit
temperatur
humid
becom
clear
asymptomat
infect
minim
symptomat
infect
occur
viru
exactli
frequent
yet
known
requir
serolog
studi
yet
undertaken
initi
report
ill
heavili
bias
sever
hospitalis
case
china
number
confirm
case
increas
within
china
elsewher
clearer
pictur
emerg
commonest
clinic
featur
fever
plu
respiratori
ill
studi
report
fever
case
dri
cough
case
fatigu
myalgia
case
dyspnoea
case
rel
frequent
manifest
includ
anorexia
product
cough
less
frequent
headach
diarrhoea
nausea
dizzi
sever
ill
death
like
occur
older
individu
possibl
preexist
clinic
ill
diabet
cardiovascular
diseas
malign
case
fatal
rate
vari
depend
popul
affect
initi
estim
base
sever
ill
patient
high
recent
estim
around
averag
significantli
higher
elderli
particularli
age
year
mani
milder
asymptomat
infect
like
miss
mortal
rate
expect
lower
publish
figur
inform
becom
avail
diseas
paediatr
patient
appear
rare
occur
mild
role
children
transmiss
remain
unknown
extens
detail
studi
need
understand
full
spectrum
ill
caus
viru
pathogenesi
diseas
especi
lung
diseas
longerterm
morbid
survivor
possibl
persist
recur
infect
especi
immunocompromis
patient
unknown
still
limit
data
import
preexist
morbid
inform
urgent
need
diseas
pregnanc
potenti
infect
fetu
understand
effect
past
exposur
coronavirus
modifi
diseas
sever
clinic
diagnosi
larg
base
clinic
exposur
histori
laboratori
chest
imag
find
laboratori
find
vari
sever
diseas
low
lymphocyt
count
common
persist
low
count
associ
poorer
test
respiratori
pathogen
undertaken
exclud
viral
bacteri
coinfect
detect
viru
base
pcr
variou
assay
direct
particularli
envelop
e
rdrp
spike
protein
nucleocapsid
n
gene
inhous
assay
use
number
public
health
laboratori
network
phln
member
laboratori
continu
ongo
evalu
addit
sever
commerci
avail
assay
claim
capac
detect
also
evalu
viru
found
upper
respiratori
tract
nearli
patient
begin
onset
clinic
prefer
sampl
combin
nasopharyng
oropharyng
swab
product
cough
also
sputum
patient
lower
respiratori
tract
infect
viru
may
detect
sputum
bronchoalveolar
lavag
sampl
even
undetect
upper
respiratori
tract
viru
cultur
rel
easili
number
cell
line
includ
vero
cell
requir
contain
laboratori
viru
identif
confirm
sequenc
necessari
larg
number
partial
whole
genom
sequenc
avail
via
gisaid
genbank
pcr
test
becom
increasingli
avail
sinc
januari
due
rapid
spread
china
huge
number
case
access
time
accur
test
problemat
especi
earli
stage
make
difficult
ascertain
true
extent
viru
infect
detail
phln
recommend
test
laboratori
biosafeti
requir
within
australia
avail
virolog
appendix
coronaviru
diseas
cdna
nation
guidelin
public
health
howev
test
still
develop
evalu
yet
confid
identifi
best
target
pcr
continu
reevalu
requir
identifi
genet
drift
may
affect
test
sensit
also
need
abl
transfer
test
onto
platform
deliv
outsid
major
laboratori
resourc
poor
set
near
patient
quickli
lack
serolog
assay
hamper
abil
understand
true
epidemiolog
viru
impact
identifi
pcrneg
infect
proven
regist
therapeut
vaccin
infect
time
treatment
larg
though
number
therapeut
investig
undergo
clinic
trial
china
elsewher
particular
interest
current
hiv
proteas
inhibitor
combin
lopinavirritonavir
new
broadspectrum
antivir
agent
call
remdesivir
shown
promis
activ
merscov
anim
model
combin
andor
ribavirin
consid
group
look
antivir
convalesc
plasma
monoclon
antibodi
work
vaccin
also
well
underway
although
unlik
vaccin
avail
least
month
coalit
epidem
prepared
innov
cepi
current
fund
four
vaccin
initi
collabor
one
univers
queensland
prof
paul
young
dr
keith
chappel
dan
watterson
use
novel
excit
molecular
clamp
technolog
develop
vaccin
work
carri
collabor
csiro
vaccin
manufactur
plant
clayton
also
partli
fund
csl
ltd
australian
collabor
hope
vaccin
readi
use
end
intern
public
health
respons
larg
base
measur
prove
success
mani
outbreak
past
decad
rapid
identif
manag
isol
case
identif
follow
contact
quarantin
measur
social
distanc
infect
prevent
control
health
care
set
commun
contain
transpar
risk
commun
well
quarantin
period
travel
china
link
ongo
transmiss
site
known
case
cruis
liner
japan
australia
respons
similar
date
moder
success
limit
number
chain
transmiss
nsw
queensland
victoria
wherea
case
elsewher
return
travel
close
contact
tabl
show
cumul
case
hubei
elsewher
china
countri
weekli
basi
januari
march
show
rapid
rise
case
china
particularli
hubei
provinc
follow
slow
past
week
continu
rise
case
outsid
china
countri
report
case
march
countri
report
case
three
countri
account
nearli
case
south
korea
case
itali
case
iran
case
report
contin
except
suggest
half
case
export
mainland
china
remain
undetect
worldwid
travel
larg
asymptomat
mild
presymptomat
travel
detect
airport
potenti
result
multipl
chain
yet
undetect
humantohuman
transmiss
outsid
mainland
although
final
call
pandem
march
mani
respect
alreadi
begun
presag
observ
new
case
report
rest
world
china
first
time
februari
addit
secondari
tertiari
chain
transmiss
report
increas
number
countri
australian
govern
alreadi
recognis
institut
emerg
respons
plan
oper
basi
pandem
seventh
coronaviru
known
infect
human
third
zoonot
viru
sarscov
merscov
bat
reservoir
host
number
addit
novel
coronavirus
particularli
chines
horsesho
bat
number
novel
coronavirus
effici
use
multipl
ortholog
sar
receptor
human
replic
effici
primari
human
airway
cell
achiev
vitro
titr
equival
epidem
strain
indic
potenti
crossspeci
event
could
occur
futur
therefor
strong
reason
ban
unregul
wild
anim
sale
chines
wet
market
particularli
exot
speci
public
health
perspect
ecolog
reason
ban
would
difficult
instig
cultur
reason
china
top
legisl
committe
februari
pass
propos
ban
trade
consumpt
wild
anim
legisl
perman
ban
might
help
reduc
risk
anoth
novel
viru
emerg
wildlif
china
futur
author
declar
conflict
interest
